How employers can join the fight against obesity

May 28, 2024

According to Mark Cunningham-Hill, chief medical director of Northeast Business Group on Health, it's possible that some people will have to take GLP-1s for life, since many patients regain most of their weight after going off the drug, which would further increase costs for employers.

It's also important that patients incorporate lifestyle changes while taking the drugs. "Too many people assume that the GLP-1s are a 'magic bullet' and that they can continue life as before and not make the other changes needed in their life," Cunningham-Hill said.

‘The Time Is Now’: How Employers Can Offer Comprehensive Obesity Care

May 19, 2024

“Even when we have that data, the indication right now is that weight loss today will equal savings 5, 10, 20 years from now, by which point a lot of these folks will no longer be employed at that company. They either have retired and moved into Medicare or they move on to another company,” said Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, in an interview.

He noted that some people start GLP-1s and then soon stop taking the drugs, adding to the difficulty of gathering the data. It’s also possible that some people will have to take these drugs for life, as many regain most of their weight after going off of the drug, said Dr. Mark Cunningham-Hill, chief medical director of Northeast Business Group on Health. This would further increase costs for employers.

In addition, it’s important that the right people take the drugs and that they incorporate lifestyle changes as well.

NEBGH: Here’s how employers can support cancer patients in the workplace

May 8, 2024

Cancer diagnoses are on the rise among younger adults, and a new guidebook seeks to arm employers with the tools necessary to tackle this issue.

The Northeast Business Group on Health's new toolkit highlights actions employers can take to proactively address growing rates for five types of cancer in their workforce: breast cancer, colorectal cancer, head and neck cancer, cancer of the reproductive organs and skin cancer.

There's a clear business case for putting a focus on cancer, as the cost of therapies continues to increase and patients often require treatment for the long haul, NEBGH Medical Director Mark Cunningham-Hill, M.D., told Fierce Healthcare.

Media Advisory: New Cancer Resources for Employers from Northeast Business Group on Health

April 24, 2024

The Northeast Business Group on Health (“NEBGH”) has just launched Cancer in Working Age Adults, a compendium of employer guides to help HR and benefit managers understand advances in preventing and detecting various cancers that are increasing among young adults, and provide support to employees affected by them. The collection of guides is the first major NEBGH initiative under the new leadership of Kim Thiboldeaux, who joined as CEO on February 1.

Cancer continues to be one of the top drivers of employer health care cost and is a top priority for NEBGH. Kim has an extensive background in healthcare, and cancer, specifically. Prior to joining NEBGH, she served as President and CEO of KDT Alliances, a health care consulting firm specializing in non-profit management, patient engagement, the patient experience, communications and health equity. Kim also served as CEO of the Cancer Support Community (CSC) for 20 years, a Washington, DC-based international non-profit organization that provides support, education and navigation for people affected by cancer.

The Cancer in Working Age Adults toolkit includes individual guides that outline risk factors for specific cancers including colorectal, breast, head and neck, skin, and cancer in reproductive organs. The guides include actions employers can take to help employees identify these cancers and support those who are affected with diagnosis, treatment, and navigation information, and social, emotional, and practical support. It also includes links to several cancer-related resources from the American Cancer Society, Skin Cancer Foundation, and the United States Preventive Services Task Force.

Given the growing prevalence of various cancers among younger working adults and the implications of cancer-related costs on employers, please contact us if you would be interested in speaking with Kim about NEBGH’s newly-launched toolkit and what actions employers can take to support employees. Dr. Mark Cunningham-Hill, NEBGH’s Medical Director, is also available for interviews. If you would like to review Cancer in Working Age Adults, you can access it here. Kim would also welcome the opportunity to discuss the goals and priorities for NEBGH and its members for 2024 and beyond.

This program was made possible with support from Pfizer.

For details and to schedule interviews, contact:
Ed Emerman

20% of women die from heart disease. Employer benefits and intervention can lead to change

February 1, 2024

Heart disease is the cause of death for one out of five women in the U.S., and is developing in younger women at an alarming rate. Employers who understand the risk factors can make sure they have the necessary benefits and support to counteract this troubling trend.

Forty-four percent of women over 20 already have some form of clinical cardiovascular disease, or CVD, according to the American Heart Association (AHA). Despite its prevalence, half of women are not aware that it is the leading cause of death among their gender, as well as the number one cause of pregnancy-related deaths, according to the Northeast Business Group on Health (NEBGH). Their research shows an even more dire outlook for women of color, with Black women having a 50% higher risk for heart failure than white women. 

Northeast Business Group on Health Appoints Kim Thiboldeaux as Chief Executive Officer

January 18, 2024

NEW YORK, January 18, 2024 -- Northeast Business Group on Health (NEBGH), a New York-based employer-led coalition of healthcare stakeholders, today announced the appointment of Kim Thiboldeaux as Chief Executive Officer. Thiboldeaux succeeds Candice Sherman, who is retiring. The appointment is effective February 1, 2024.

“We are extremely fortunate to have someone with Kim’s background lead our organization,” said Sandi Stein, Chair of NEBGH’s Board of Directors. “Her deep health care experience in both the corporate and non-profit sectors makes her the ideal candidate to support our mission and values. All of us look forward to Kim’s leadership and contributions to our organization and members.”

Prior to joining NEBGH, Thiboldeaux served as President and CEO of KDT Alliances, a health care consulting firm specializing in non-profit management, patient engagement and the patient experience, communications and health equity. She also served as CEO of the Cancer Support Community (CSC) for 20 years, a Washington, DC-based international non-profit organization that provides support, education and navigation for people affected by cancer. During her tenure at CSC, Kim grew the organization fivefold and executed two successful mergers. Thiboldeaux also held various health care positions at Hoffman-LaRoche and Washington, DC law firms. She earned a bachelor’s degree in communications from American University.

“It is an incredible honor to have the opportunity to lead NEBGH as we continue to serve employers and other health care industry stakeholders,” said Thiboldeaux. “I look forward to working with the organization and its members as we all strive to provide high quality, affordable health care to employees and families.”

"On behalf of the Board, I also want to thank Candice for her outstanding leadership over the past 10 years,” said Stein. “During her tenure, Candice has spearheaded important initiatives to help our members deliver world-class solutions to many of the complex health care benefit issues they are facing. We wish her all the best in her future endeavors.”  

NEBGH is an employer-led, multi-stakeholder coalition that empowers members to drive excellence in health and achieve the highest value in healthcare delivery and the consumer experience. NEBGH employer/purchaser members cover 8 million lives in the U.S. and 12 million globally.

Media contact:
Ed Emerman

2024 Employer Sponsored Health Plan Predictions: GLP-1s, Vendors, Data

January 3, 2024

Employers are stuck between a rock and a hard place in 2024, with unsustainable healthcare spending in their employer-sponsored health plans and a reticence to shift any more of the cost to their workers.

Some experts are calling the new year “2023 2.0” because companies faced the same dilemma in 2023. The year before that in 2022, employers tried to shift costs from premiums to out-of-pocket spending. In 2024, however, this approach is not as attractive because it may drive away potential job candidates and drive out current employees.

As a result, 2024 is the year that employers must be creative to reduce healthcare costs.

Candice Sherman, chief executive officer of the North East Business Group on Health (NEBGH), and Drew Hodgson, actuary and national practice leader of health care delivery at Willis Towers Watson, shared with HealthPayerIntelligence some of the strategies successful employers may implement to overcome cost barriers in the new year.

Cost is the biggest concern

The resounding theme across the healthcare system at the start of 2024 is: healthcare spending is astronomical, it is only getting higher, and it will be a major factor for all healthcare leaders.

Employers are no exception. In fact, they are in a strategic but challenging position to influence the final cost for patients by bearing the brunt of the expense. As a result, they have a vested interest in healthcare spending and will be responsive to fluctuations.

Employers anticipate the total health benefit cost per employee to increase 5.4 percent in 2024 on average, according to Mercer. If they leave their plans as-is, employers indicated the cost growth would be even higher, around 6.6 percent on average. Other sources project even higher costs, with Aon anticipating an 8.5 percent growth in employer healthcare spending.

“Most of the employers that we speak with are not eager to impose those extra costs on employees because of concerns about attracting and retaining employees,” Sherman explained. “And so I think employers are looking for other levers to pull that will enable them to continue to offer a robust benefits equation for employees without battling them with additional costs.”

Mercer experts noted a couple of key drivers to this trend, including healthcare consolidation and high costs for popular prescriptions.

Consolidation can have its benefits, but it also tends to increase premiums.

“We've seen a lot of health systems and providers having financial strains—especially ones that were still fee-for-service rather than being based on value-based care—[and] consolidation within the hospital space,” said Hodgson. “And whenever you consolidate, prices start to go up, and we're already seeing a ton of difficult negotiations between insurance companies and healthcare providers and health systems.”

In addition to the factors that the Mercer study underscored, Hodgson noted that data transparency had increased costs, instead of leading to spending cuts. Once providers had the ability to see what their peers were making on certain services, they began to demand greater reimbursement from payers.

A third factor that Hodgson highlighted was utilization. After a couple of wild years of oscillation due to the coronavirus pandemic, when healthcare utilization dropped to a 7.0 percent decline in growth and then shot up to an 8.6 percent increase in growth, utilization rates seem to have stabilized. In 2022, the average quantity index of healthcare services grew 3.1 percent, which represented typical growth trends pre-pandemic.

However, even stabilized growth is still growth. From 2006 through 2013, the average quantity index of healthcare services never exceeded a 2.5 percent increase. The 2022 quantity index may be stabilizing but it remains on the higher end of the trend.

In 2024, Hodgson expected utilization to increase. He found that some of the growth was profit-driven and reflected the need for a broader uptake of value-based care. GLP-1 use would drive utilization trends higher.

Employers’ cost-cutting efforts for the past year may have been working. The spending increase should have been higher in 2024, given the massive inflation rates of the past two years.

Drug coverage will extend beyond medications

The previous year was momentous for the pharmaceutical industry. In 2023, these companies introduced a number of drugs targeting widespread and debilitating conditions, such as the first over-the-counter contraceptive, an antidepressant for postpartum depression, and a controversial treatment for Alzheimer’s.

The drug category that sparked the most buzz, however, was the glucagon-like peptide 1 (GLP-1). Most GLP-1 drugs were created to control diabetes with the potential for weight loss. But some, like Mounjaro, Wegovy, and Zepbound, have an additional objective: to treat chronic weight management.

GLP-1s gained greater popularity in 2023 as weight loss treatments. And employers are starting to follow employees’ lead, with the number of employers planning to cover GLP-1 drugs in 2024 expected to double, according to a survey from Accolade. Most of those who already cover the drug say the decision led to higher employee satisfaction and well-being (75 percent).

However, this drug type, with its many uses, poses a significant challenge for employers. According to PwC, GLP-1 drug prices cost $10,000 a year or more. Wegovy’s price tag, for example, is around $17,000 per year.

The impact of GLP-1 coverage on overall healthcare spending extends beyond price. Even if it was not so expensive, the overwhelming demand for these drugs would likely impact spending.

Hodgson attributed GLP-1s with driving up utilization which, in turn, will drive up costs for 2024. He compared the drug’s arrival to that of Xanax and opioids. Both became popular quickly and developed ulterior uses, which, along with other downstream impacts including employment outcomes, contributed to higher spending.

Controlling overprescription is possible, as evidenced by the declining prescription rates for both Xanax and opioids. But it took decades of excessive spending to achieve those lower rates.

GLP-1s could follow a similar trajectory if healthcare leaders and employers are not careful. The patient outcomes of overprescribing or off-label prescribing of GLP-1s might not be as severe as for addictive, potentially deadly drugs like Xanax and opioids, but it could still have lasting effects on employers’ and employees’ financial strain.

“Employers really have to have a GLP-1 strategy about how they're going to cover these drugs, when they're going to cover these drugs, what authorizations need to be in place now before it starts to escalate and get out of control,” Hodgson said.

Sherman emphasized that employers need to provide wraparound support for employees who receive the medication. Such services include dietary coaching, nutritional education, exercise benefits, and behavioral health support.

These wraparound supports are not intended to replace the medication, Sherman clarified. Rather, they ensure that employees and their families have ways to manage their costs and can pursue holistic care.

Data will be central to strong decisionmaking

Beneath the pressures of looming costs and vendors’ proposals, overwhelmed employers can start the year by securing sufficient data.

“A lot of times, plan sponsors have basically gone out to bid every three years, gone to the major carriers, looked at discounts and said, ‘Okay, they're cheaper. I'm going with that.’ Those days have got to end. Those days are over,” Hodgson asserted.

Companies can no longer let discounts alone determine their benefits and plan options. Instead, Hodgson encouraged employers to use their workforce data to drive what solutions are best suited to their employees. Depending on the data, traditional solutions like virtual care, centers of excellence, and accountable care organizations may still be worth the investment.

“Without data, you're nowhere. You have to have that bedrock of data to understand what's happening and ‘where do I expect everything to go in the next year or two,’ and then have a strategy from the opportunity side to really look through a lot of these types of solutions in the market,” Hodgson explained.

Employers will reassess benefits for equity

Data will also help employers determine if every employee population has equal access to healthcare. After a Deloitte report revealed strong disparities in the costs of healthcare benefits for female employees compared to their male counterparts, employers will be refining their women’s health benefits.

In addition to evaluating benefits based on gender and sexual orientation, employers will assess benefits by generation.

“The other thing that we're hearing from our members is just the fact that many of them have as many as five different generations in their workforce now. So how do you develop an array of benefits that give people what they need at those different stages of life?” Sherman summarized.

Assessing benefit equity based on race and ethnicity is also crucial. People of color are more likely to miss work for health-related reasons than their White colleagues, according to McKinsey. Plus, among employees with household incomes of under $100,000, seven in ten employees of color lacked two or more basic needs such as housing or transportation (69 percent), compared to five in ten White employees (49 percent).

Employers should also stratify their benefits analyses based on income, Sherman suggested.

“Something that works for someone at a very high income may not work for someone at a lower income level. So you want to make sure that you're offering not equal benefits, but benefits that provide equity,” advised Sherman.

Point solutions will require reevaluation

Once employers have gathered all the right data and conferred with their consultants or brokers, they will start reassessing their benefits and point solutions.

Employers are offering a smorgasbord of point solutions, Hodgson indicated. Half of employers offer four to nine point solutions, but large companies can have over 20 or 30 solutions. Hodgson has encountered employers offering more than 45 point solutions to their workforces.

This issue did not occur by happenstance. The coronavirus pandemic led to a surge in telehealth adoption, particularly in the mental and behavioral healthcare space. Growth in access to digital health resources and other types of vendor point solutions can be a good thing, but only if these tools are producing better outcomes.

In 2024, vendors will experience a reckoning. Employers will assess the solutions that they selected in recent years and determine whether the return on investment is satisfactory. Any solutions that are not producing outcomes will be slashed as employers reduce wasteful spending.

Nearly a third of employers (32 percent) are putting vendors or health plans out to bid in 2024 and 47 percent are considering doing the same, according to a WTW survey. In 2022, only a quarter of employer respondents in a separate WTW survey said they made changes to their clinical point solutions and a quarter planned to do so over the next couple years.

The key metric will be integration. Employers will reassess their vendor solutions based on how the tools and offerings integrate into their existing ecosystem of benefits and digital health options, Hodgson shared. Without easy navigability, employees will not use the point solutions and the investment will be meaningless.

“Make sure that this is something that is going to fit well into your overall benefits, so that you can get the utilization,” Hodgson urged. “We see it all the time where someone will put a vendor in place and we think it's great, it's going to save money, and nobody uses it. It's a huge problem. So when you have 20, 30 different vendors, that happens all the time.”

Sherman specifically highlighted the necessity for better organization of mental and behavioral health support tools.

Most self-insured companies have established a mental health continuum, Sherman observed. For these large organizations, the question is less about whether they will offer mental health support and more about how to make it accessible.

“How do you create something so that employees know how to navigate: ‘I'm having this kind of mental health issue, so what's available to me?’ So, I think really trying to organize that into a continuum that makes sense, that's easy to navigate, and it's clear where to go for what is going to be key,” Sherman said.

Sherman also noted that this challenge for employers presents an opportunity for health plans.

“There's an opportunity there for health plans who have increasingly become adept at using digital partners that make sense. They'll be offering employers some tools and some ways of integrating into a digital menu that might make sense,” Sherman shared.

As employers start the new year, their strategies will center on lowering costs and making wise partnership decisions.

US physical health on the decline, with implications for employers

December 20, 2023

  • Physical health in the U.S. has worsened since the onset of the COVID-19 pandemic, a shift that could have detrimental effects on employers, according to Gallup survey results released Dec. 14. 
  • Both obesity and diabetes are on the rise, Gallup found. The percentage of U.S. adults Gallup determined to have diabetes is 38.4%, up 6 percentage points from 2019 and a hair behind the record high 39.9% recorded last year. The number of respondents who said they have diabetes hit a new high of 13.6%, an increase of 1.1 points since 2019, per Gallup. 
  • “These health effects have practical implications for the U.S. economy. After controlling for factors such as age, income and education, workers with poor physical health — and poor wellbeing generally — suffer greatly enhanced levels of unplanned absenteeism and healthcare utilization (and associated costs) than do their counterparts,” Dan Witters, research director of the Gallup National Health and Well-Being Index, said.

Employers could do more to support women’s cardiovascular health, group says

December 14, 2023

Dive Brief:

  • Cardiovascular disease is underdiagnosed and undertreated in women, and employers could make changes to their benefits programs that address risk factors, create more inclusive cultures and attract talent, the Northeast Business Group on Health said in an employer guide released Nov. 30.
  • Statistics from the Centers for Disease Control and Prevention show heart disease was responsible for 1 in 5 female deaths in 2021, but only 56% of U.S. women recognized heart disease as a leading cause of death. Women may experience different symptoms of heart disease than men do, NEBGH said. Treatments for cardiovascular disease and its risk factors, such as diabetes and obesity, are underused.
  • NEBGH recommended employers devise strategies for determining which benefits programs they are missing and work with their health plans to examine claims data. Other strategies include structuring benefits to ensure equity; take steps to reduce drug copayments; and educating employees on becoming better healthcare consumers.

How Employers Can Promote Cardiovascular Care, Women’s Health

December 6, 2023

Employers can implement a number of strategies to raise awareness and promote access to cardiovascular care to support women’s health.